What is Proton Intelligence?
Proton Intelligence is dedicated to revolutionizing hyperkalemia management, particularly for individuals with chronic kidney disease (CKD) and heart failure. The company is developing a pioneering wearable device for continuous, real-time potassium monitoring. This technology aims to provide clinicians with the precise tools needed to safely manage patients at risk of hyperkalemia, addressing a significant unmet need for over 3.7 million Americans affected by high potassium levels. Their focus on healthcare providers and patients requiring diligent potassium oversight positions them as a key player in advanced patient monitoring.
How much funding has Proton Intelligence raised?
Proton Intelligence has raised a total of $7M across 1 funding round:
Angel/Seed
$7M
Angel/Seed (2024): $7M with participation from Tenmile, 15th Rock Ventures, SOSV, EXOR, and We Venture
Key Investors in Proton Intelligence
Tenmile
Tenmile is an investment firm focused on improving human health by supporting innovative companies in the health sector. They partner with teams addressing significant unmet health needs, providing capital, expertise, and connections to help translate scientific breakthroughs into scalable solutions.
15th Rock Ventures
15th Rock is a venture capital firm specializing in the enhancement of human capabilities through technology. They aim to support startups that can transform conventional human abilities, enabling actions such as flying or becoming invisible.
SOSV
SOSV is a multi-stage venture capital investor that provides intellectual and financial capital to accelerate founders big ideas.
What's next for Proton Intelligence?
With the recent influx of major strategic investment, Proton Intelligence is poised for significant expansion and product development. The enterprise-level funding suggests a focus on scaling operations, enhancing manufacturing capabilities for their continuous potassium monitoring wearable, and potentially broadening market reach. This capital infusion will likely accelerate clinical validation and regulatory approvals, paving the way for wider adoption by healthcare providers and improved patient outcomes in hyperkalemia management. The company's trajectory indicates a strong commitment to innovation in chronic disease management.
See full Proton Intelligence company page
